Autumn McRee
Hematology & Oncology · Chapel Hill, NCNPI 1609923499
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,300 of the $7,549 with a category attached, or 83.5%. Every reported general payment came from a single manufacturer, Merck.
Across 9 payments — averaging $838.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$8K
Across 109 payments — averaging $50,230 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$2.7M
- Pfizer$1.4M
- Amgen$727K
- AstraZeneca$301K
- Genentech, Inc.$271K
- Boston Scientific$31K
- plus $26K from 2 others
What the payments were for
- Consulting fees$6,30083%
- Travel & lodging$98913%
- Food & beverage$2603%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $7,549 |
How this compares
$7,549 in reported general payments places this provider in the 70th percentile of 358 hematology & oncology providers in North Carolina.
Other hematology & oncology in Chapel Hill
- Jared WeissChapel Hill$217K
- Joshua ZeidnerChapel Hill$208K
- Brandi ReevesChapel Hill$198K
- Nigel KeyChapel Hill$174K
- Norman SharplessChapel Hill$125K
- Lisa CareyChapel Hill$51K
- Alice MaChapel Hill$42K
- Thomas SheaChapel Hill$24K
- Juneko Grilley OlsonChapel Hill$24K
- Amit MehtaCary$4.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.